Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 71 results found. Search for [ India's second-largest drug company ]

Results 1 to 21 of 71
E Kumar Sharma
New Delhi, July 8, 2019
The path to product and profitability for stem cell players is fraught with challenges


BusinessToday.In
May 30, 2019
Share Market Updates: Suzlon, Justdial, Infibeam, DCM Shriram and Adani Power were the top gainers on BSE, while on NSE, YES Bank, Bharti Airtel, NTPC, TCS and Bajaj Finance were the top gaining stocks.


BusinessToday.In
May 22, 2019
Share Market Update:  Indian Benchmark indices extended gains in the afternoon session to close on the positive side, backed up by gains in Bank, Realty, Auto and Financial Services. However, India Vix index, that subjects volatility in the market, was up at 27, ahead of counting of Lok Sabha Election 2019 to be done on May 23.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


PTI
December 21, 2018



BusinessToday.In
New Delhi, December 21, 2018
Indian drugs regulator asks J&J to stop making baby powder using raw materialsOur very trusted baby brand Johnson and Johnson is in deep trouble. India's drugs regulator has ordered Johnson & Johnson to stop manufacturing its Baby Powder using raw materials in two of its Indian factories until test results prove they are free of asbestos. The official at the Central Drugs Standard Control Organization (CDSCO), said a written order had been sent to the U.S. company telling it to stop u...


PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


PB Jayakumar
New Delhi, October 29, 2018
A big transformation is happening in the global generic pharmaceutical industry. As a result, stocks of most major drug companies have done badly in the past one year.


Team BT
New Delhi, June 25, 2018
Indian promoters take home fat pay cheques but their compensation is, in most cases, linked to company performance.


Joe C Mathew
New Delhi, May 15, 2018
The bidding war has raised the value of each Fortis share nearly 50% from the lowest offer of Rs 126 per share to Rs 185 per share. So what makes Fortis so valuable?


Rita McGrath and M. Muneer
New Delhi, April 30, 2018
Payment should be based on value, not activities.


PB Jayakumar
New Delhi, February 19, 2018
Abbott Indias employee value proposition strategy focuses on flexi-benefits, participation of women and nurturing future leaders.


PB Jayakumar
New Delhi, January 16, 2018
Pegged at over Rs 18,862 crore by a Nicholas Hall 2017 report, the Indian OTC market is expected to grow at a compounded annual growth rate (CAGR) of 9 percent to cross Rs 44,115 crore.


BusinessToday.in
November 30, 2017
Of 30 Sensex stocks, 26 are trading in the red. Sun Pharma (0.82 percent), Bajaj Auto (0.56 percent), Dr Reddy's (0.31 percent) top gainers.


E. Kumar Sharma
New Delhi, November 25, 2017
Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.


BT Online
November 3, 2017
Footwear retailer Khadim India's initial public offer was subscribed 14 percent on the first day of bidding on Thursday. The IPO, which aims to raise Rs 543 crore, received bids for 7,16,960 shares against the total issue size of 50,73,006 shares.


BT Online
October 30, 2017
Energy firms gained on higher crude prices as sentiment was upbeat in domestic and global energy stocks with Brent crude hitting its highest level since July 2015 after Saudi Arabia agreed to support the extension of a global oil production cut agreement. While Reliance Industries gained over 1 percent, the ONGC stock rose up to 4 per cent post its Q2 earnings.


PB Jayakumar
New Delhi, October 11, 2017
The acquisition of Symbiomix and the 'Solosec' franchise will help Lupin expand its women's health specialty business. Lupin will pay $50 million upfront and the remaining $100 million over the next five years.


By P.B. Jayakumar
NA, July 22, 2017
Ajay Piramal is betting on real estate and financial services to create a $20 billion business by 2020. The Shriram Capital-IDFC deal will fast-track his march.


PAGES 1 OF 4  1234